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Clinics and pathology 
Disease 
Myeloproliferative disease evolving towards a M5-
AML; the t(4;21) may be therapy related. 
Epidemiology 
Only one case to date, a female patient aged 74 years 
(Jeandidier et al., 2006). 
Cytogenetics 
Additional anomalies 
Unrelated clones; one of which with +8, another one 
with +21. 
Genes involved and proteins 
Note 







Contains a Runt domain and, in the C-term, a 
transactivation domain; forms heterodimers; widely 
expressed; nuclear localisation; transcription factor 
(activator) for various hematopoietic-specific genes. 
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